Consumer Reports has taken a close look at the dangers of prescription and over-the-counter painkillers and is calling on the U.S. Food and Drug Administration to do more to make these drugs safer. The full report, "Deadly Pain Pills" is featured in the September 2014 issue of Consumer Reports magazine and is available at http://www.ConsumerReports
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 30, 2014/ PRNewswire/ Eisai Inc. and Arena Pharmaceuticals, Inc. announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of Week 52 Weight-Loss Outcomes," was recently
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro Pharmaceuticals U.S.A., Inc., the owner of the Reference Listed Drug of its filing. On July 28, 2014, Taro filed suit against Perrigo in the United States D
At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment; the Global Vaccines, Oncology and Consumer Healthcare segment; and the Global Established Pharmaceutical segment.
YANTAI, CHINA/ ACCESSWIRE/ July 28, 2014/ Bohai Pharmaceuticals Group, Inc., a leading manufacturer and marketer of traditional Chinese medicine, today said it has updated its company website to include new corporate and industry information. Bohai Pharmaceuticals Group A manufacturer and marketer of traditional Chinese medicine in the People s
Medical revenues in China- your guide to trends, companies and potentials What's the outlook for the Chinese pharma market? Can it sustain high growth? China still holds great potential for medicines and their sales.
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 29, 2014/ PRNewswire/ Eisai Inc. and Arena Pharmaceuticals, Inc. announced today that BELVIQ has been nominated by the Galien Foundation and Awards Committee for the 2014 Prix Galien USA Award in the Best Pharmaceutical Agent category. "The Prix Galien USA Award recognizes the extensive research necess
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration. Location: FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room, Silver Spring, MD 20993-0002. Information regarding special accommodations due to a disability, visitor parking, and transportation m
Pfizer Inc. reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment; the Global Vaccines, Oncology and Consumer Healthcare segment; and.
During the negotiations for the 2007 reauthorization of the Prescription Drug User Fee Amendments Act, FDA agreed to several performance goals related to the review of drug and biological product proprietary names to reduce medication error. Among those goals, FDA and industry expressed an interest in exploring the possibility of "reserving" propri
By a News Reporter-Staff News Editor at Diabetes Week Johnson& Johnson announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%. Net earnings and diluted earnings per share for the second quarter o
Public Citizen issued the following news release:. The U.S. Food and Drug Administration should not allow over-the-counter benzocaine products to be marketed for treating teething in infants and toddlers because they can prompt a rare but potentially deadly adverse reaction, Public Citizen said today in a petition to the agency. In addition, the ag
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA NeuroMetrix, Inc. announced that its wearable technology for treatment of chronic pain received 510 clearance from the U.S. Food and Drug Administration for over-the-counter use. "Patient response to SENSUS, our prescription wearable device for treatment of chronic pain, has
One possible strategy is taking potassium supplements a practice that appears to reduce mortality, according to a new University of Pennsylvania study. The Food and Drug Administration recently approved a wireless implantable device so physicians can keep tabs on the pressure in their patients' pulmonary arteries a device tested at Einstein Med
LONDON- A regulatory application for malaria vaccine candidate, RTS, S, submitted to the European Medicines Agency by GlaxoSmithKline plc has been accepted for review, thus becoming the world's first malaria vaccine candidate to undergo regulatory review. AGEN rose 11.15% to close Thursday's trading at $3.39. Cynosure Inc.' s flagship product PicoS
GlaxoSmithKline plc today announced that the U.S. Food and Drug Administration has approved Flonase Allergy Relief, containing the No. 1 prescribed allergy treatment ingredient, as an over-the-counter treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies. Roughly 50 million people in the United States suffer
In July 2014, the Company announced that the Japanese Ministry of Health, Labor and Welfare approved Daklinza and Sunvepra for Japan's first all-oral, interferon- and ribavirin-free treatment regimen for patients with genotype 1 chronic hepatitis C virus infection, particularly those with compensated cirrhosis. In July 2014, the Company and Ono...
GlaxoSmithKline plc today announced that the U.S. Food and Drug Administration has approved Flonase Allergy Relief, containing the No. 1 prescribed allergy treatment ingredient 1, as an over-the-counter treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies. 2. Roughly 50 million people in the United States
MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to medication non-adherence and hospital readmission rates specified in a study published in a recent issue of the Annals of Inter
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy, HIV and Multiple Sclerosis, is announcing that they are in the process of completing critical capital improvements to their warehouse and fulfillment center in order to meet increased demand and shipments of their over-the-counter pain reliever,..
Perrigo Company today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration for its previously approved New Drug Application for testosterone gel 1.0%. FDA concluded that Perrigo's testosterone product is therapeutically equivalent to AndroGel 1% and can be substituted with the full expectat
Nigel Fleming, founder and former Chairman of Athena Diagnostics; and Kazuhiro Umeda, former President of JAIC Singapore, Indonesia, and Thailand. It named Moosa Areff, who most recently served as CEO of Ranbaxy South Africa's Sonke Pharmaceuticals subsidiary, as its Chief Operating Officer. Mr. Luthuli noted that the appointments come as the Sub-S